Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
899 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01905943 | A Safety and Efficacy Study of Obinutuzumab Alone or in Combination With Chemotherapy in Participants With Chronic Lymphocytic Leukemia | completed | Phase 3 | 979 | Hoffmann-La RocheINDUSTRY | 31 | Oct 28, 2019 | clinicaltrials |
| NCT03035591 | ODM-207 in Patients With Advance Solid Tumours(BETIDES) | completed | Phase 1 / Phase 2 | 36 | Orion Corporation, Orion PharmaINDUSTRY | 1 | Oct 15, 2019 |
| NCT01774760 | Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck Cancer | completed | Phase 2 | 10 | Turku University HospitalOTHER_GOV | 1 | Oct 4, 2019 | clinicaltrials |
| NCT01183780 | A Study in Second Line Metastatic Colorectal Cancer | completed | Phase 3 | 1,072 | Eli Lilly and CompanyINDUSTRY | 26 | Sep 25, 2019 | clinicaltrials |
| NCT03650517 | Minimally Invasive Right Colectomy Anastomosis Study(MIRCAST) | unknown | — | 1,200 | Instituto de Investigación Marqués de ValdecillaOTHER | 10 | Sep 25, 2019 | clinicaltrials |
| NCT02526602 | Preservation of Endopelvic Fascia: Effects on Postoperative Incontinence and Impotence. Randomized Clinical Trial. | completed | N/A | 158 | Tampere University HospitalOTHER | 1 | Sep 18, 2019 | clinicaltrials |
| NCT00087711 | A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer | completed | Phase 3 | 1,713 | Eli Lilly and CompanyINDUSTRY | 27 | Sep 12, 2019 | clinicaltrials |
| NCT00191243 | Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer | completed | Phase 2 | 237 | Eli Lilly and CompanyINDUSTRY | 1 | Sep 12, 2019 | clinicaltrials |
| NCT04050397 | Exercise and Quality of Life During Androgen Deprivation Therapy | unknown | N/A | 40 | Tampere University HospitalOTHER | 1 | Sep 11, 2019 | clinicaltrials |
| NCT00137995 | R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma | completed | Phase 3 | 481 | Lymphoma Study AssociationOTHER | 10 | Aug 28, 2019 | clinicaltrials |
| NCT02464709 | Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL) | completed | Phase 4 | 72 | Joint Authority for Päijät-Häme Social and Health CareOTHER | 1 | Aug 28, 2019 | clinicaltrials |
| NCT01675102 | Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in 17p- Chronic Lymphocytic Leukemia (CLL)(17p-CLL) | completed | — | 41 | European Society for Blood and Marrow TransplantationNETWORK | 7 | Aug 16, 2019 | clinicaltrials |
| NCT04001023 | Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia(OVANOX) | unknown | N/A | 40 | Turku University HospitalOTHER_GOV | 1 | Aug 7, 2019 | clinicaltrials |
| NCT04037150 | Circulating DNA in Surgically Treated NSCLC | unknown | — | 100 | Helsinki University Central HospitalOTHER | 1 | Aug 6, 2019 | clinicaltrials |
| NCT02389101 | Molecular and Whole-body MR Imaging in Lymphomas(MILY) | completed | N/A | 21 | Turku University HospitalOTHER_GOV | 1 | Aug 5, 2019 | clinicaltrials |
| NCT02302807 | A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] | completed | Phase 3 | 931 | Hoffmann-La RocheINDUSTRY | 29 | Aug 1, 2019 | clinicaltrials |
| NCT01039376 | Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy(PROLONG) | terminated | Phase 3 | 480 | Novartis PharmaceuticalsINDUSTRY | 25 | Jul 30, 2019 | clinicaltrials |
| NCT01997229 | Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study) | completed | Phase 3 | 125 | Alexion Pharmaceuticals, Inc.INDUSTRY | 21 | Jul 16, 2019 | clinicaltrials |
| NCT01310894 | Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.(PCM301) | completed | Phase 3 | 413 | Steba Biotech S.A.OTHER | 10 | Jul 11, 2019 | clinicaltrials |
| NCT01234350 | A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGON | completed | — | 1,493 | Ferring PharmaceuticalsINDUSTRY | 15 | Jun 25, 2019 | clinicaltrials |
| NCT00568750 | Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors | completed | Phase 2 | 47 | Swiss Cancer InstituteOTHER | 4 | Jun 17, 2019 | clinicaltrials |
| NCT01367665 | STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma | completed | Phase 2 | 1,232 | Hoffmann-La RocheINDUSTRY | 37 | Jun 6, 2019 | clinicaltrials |
| NCT01466777 | Endometrial Cancer and Robotic-assisted Versus Traditional Laparoscopy | unknown | N/A | 100 | Tampere University HospitalOTHER | 1 | Jun 6, 2019 | clinicaltrials |
| NCT01308567 | Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer(FIRSTANA) | completed | Phase 3 | 1,168 | SanofiINDUSTRY | 25 | Jun 5, 2019 | clinicaltrials |
| NCT03926468 | Liquid Biopsy in Head and Neck Cancer | unknown | — | 30 | Turku University HospitalOTHER_GOV | 1 | Jun 4, 2019 | clinicaltrials |
| NCT01538680 | Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy(CONSIGN) | no longer available | — | — | BayerINDUSTRY | 25 | May 29, 2019 | clinicaltrials |
| NCT03937401 | Oxytocin in MRI-HIFU | unknown | Phase 4 | 100 | Turku University HospitalOTHER_GOV | 1 | May 3, 2019 | clinicaltrials |
| NCT02914704 | Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU) | unknown | N/A | 500 | Turku University HospitalOTHER_GOV | 1 | Apr 29, 2019 | clinicaltrials |
| NCT00979641 | Biweekly Avastin and Docetaxel as the First Line Treatment for Patients With Metastatic Breast Cancer(AINO) | terminated | Phase 2 | 65 | Tampere University HospitalOTHER | 1 | Mar 28, 2019 | clinicaltrials |
| NCT02367547 | Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL | unknown | Phase 1 / Phase 2 | 117 | Joint Authority for Päijät-Häme Social and Health CareOTHER | 1 | Mar 28, 2019 | clinicaltrials |
| NCT01567111 | 11C-Metomidate PET Versus Adrenal Vein Sampling in Primary Aldosteronism(MIA) | completed | N/A | 40 | Helsinki University Central HospitalOTHER | 1 | Mar 11, 2019 | clinicaltrials |
| NCT00646854 | Alemtuzumab and CHOP in T-cell Lymphoma(ACT-1) | completed | Phase 3 | 136 | Aarhus University HospitalOTHER | 11 | Mar 1, 2019 | clinicaltrials |
| NCT01790737 | First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02(FMG-MM02) | completed | Phase 2 | 80 | Kuopio University HospitalOTHER | 1 | Mar 1, 2019 | clinicaltrials |
| NCT00639210 | BREAST CANCER AND EXERCISE(BREX) | completed | Phase 3 | 573 | Finnish Breast Cancer GroupOTHER | 1 | Feb 26, 2019 | clinicaltrials |
| NCT01633060 | A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi(BELLE-3) | terminated | Phase 3 | 432 | Novartis PharmaceuticalsINDUSTRY | 22 | Jan 30, 2019 | clinicaltrials |
| NCT01564784 | A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia | completed | Phase 3 | 326 | PfizerINDUSTRY | 20 | Jan 9, 2019 | clinicaltrials |
| NCT01193257 | Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer. | completed | Phase 3 | 1,099 | Millennium Pharmaceuticals, Inc.INDUSTRY | 14 | Dec 19, 2018 | clinicaltrials |
| NCT00789373 | A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung Cancer | completed | Phase 3 | 939 | Eli Lilly and CompanyINDUSTRY | 15 | Dec 14, 2018 | clinicaltrials |
| NCT01200758 | A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma | completed | Phase 3 | 410 | Hoffmann-La RocheINDUSTRY | 30 | Nov 27, 2018 | clinicaltrials |
| NCT02620228 | Identification of Liver Tumours Using BIP - Biopsy System | completed | N/A | 26 | Injeq LtdINDUSTRY | 1 | Nov 21, 2018 | clinicaltrials |
| NCT03527784 | Prestoma-Trial for Parastomal Hernia Prevention | terminated | N/A | 14 | University of OuluOTHER | 1 | Nov 5, 2018 | clinicaltrials |
| NCT02472977 | Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors(CXCessoR4) | terminated | Phase 1 / Phase 2 | 61 | Bristol-Myers SquibbINDUSTRY | 2 | Nov 1, 2018 | clinicaltrials |
| NCT03420924 | Thermal Suit With Forced-air Warming in Breast Cancer Surgery | completed | N/A | 40 | Tampere University HospitalOTHER | 1 | Oct 30, 2018 | clinicaltrials |
| NCT01463813 | Finnish Vitamin D Trial (FIND)(FIND) | completed | N/A | 2,495 | University of Eastern FinlandOTHER | 1 | Oct 23, 2018 | clinicaltrials |
| NCT00838201 | Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer | completed | Phase 3 | 384 | AmgenINDUSTRY | 6 | Oct 18, 2018 | clinicaltrials |
| NCT01866553 | Nilotinib Plus Pegylated Interferon-α2b in CML | terminated | Phase 2 | 20 | Amsterdam UMC, location VUmcOTHER | 5 | Oct 12, 2018 | clinicaltrials |
| NCT01305655 | Glucarpidase Effect on Severe Delayed HDM-clearance in Children Treated With High-dose Mtx in ALL(NOPHOCPG2) | completed | Phase 3 | 47 | Nordic Society for Pediatric Hematology and OncologyOTHER | 5 | Sep 28, 2018 | clinicaltrials |
| NCT00309166 | Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males. | completed | Phase 2 | 270 | GlaxoSmithKlineINDUSTRY | 1 | Sep 17, 2018 | clinicaltrials |
| NCT00332202 | PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin | completed | Phase 3 | 758 | Eli Lilly and CompanyINDUSTRY | 25 | Sep 10, 2018 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials